Loading provider…
Loading provider…
Gastroenterology Physician in New York, NY
NPI: 1144489105Primary Practice Location
MOUNT SINAI HOSPITAL
1184 5th Ave, New York, NY
Primary Employer
Gastroenterology Division of Mount Sinai
icahn.mssm.edu
HQ Phone
Get M.D. Ari's Phone Numberphone_androidMobile
Get M.D. Ari's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Albert Einstein College of Medicine of Yeshiva University
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 71 | 85 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 67 | 69 |
| 3 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 66 | 66 |
| 4 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | 59 |
| 5 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 56 | 56 |
Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.
Authors: Emily Tixier, Ryan Ungaro
Publication Date: 2019-06-18
Authors: Loren Rabinowitz, Bruce Sands, Stephanie Gold, Ryan Ungaro
Journal: Inflamm Bowel Dis
A Systematic Review of Fecal Microbiota Transplant for the Management of Pouchitis.
Authors: Kayal, Maia, Lambin, Thomas, Pinotti, Rachel, Dubinsky, Marla C, Grinspan, Ari
Journal: Crohns Colitis 360
Publication Date: 2020-05-12
Lead Sponsor: Ari M Grinspan
Intervention / Treatment: DRUG: Placebo, DRUG: Metronidazole, DRUG: Vancomycin, BIOLOGICAL: Fecal Microbiota Transplantation
Lead Sponsor: Microbiome Health Research Institute
Collaborators: Indiana University, Tufts Medical Center, Edward Hospital, Brown University
Intervention / Treatment: DRUG: Fecal Microbiota Preparation
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Risankizumab On-Body Injector (OBI), DRUG: Placebo for Risankizumab SC, DRUG: Risankizumab IV, DRUG: Placebo for Risankizumab IV, DRUG: Risankizumab SC